HEADER TRANSPORT PROTEIN/INHIBITOR 30-MAR-15 4Z36 TITLE CRYSTAL STRUCTURE OF HUMAN LYSOPHOSPHATIDIC ACID RECEPTOR 1 IN COMPLEX TITLE 2 WITH ONO-3080573 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOPHOSPHATIDIC ACID RECEPTOR 1,SOLUBLE CYTOCHROME B562; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 2-232; UNP RESIDUES 23-64; UNP RESIDUES 78- COMPND 5 127; UNP RESIDUES 249-327; COMPND 6 SYNONYM: LPA-1,LYSOPHOSPHATIDIC ACID RECEPTOR EDG-2,CYTOCHROME B-562, COMPND 7 CYTOCHROME B-562,LPA-1,LYSOPHOSPHATIDIC ACID RECEPTOR EDG-2; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: LPAR1, EDG2, LPA1, CYBC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-1711; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS HUMAN LYSOPHOSPHATIDIC ACID RECEPTOR 1 (LPA1), G-PROTEIN COUPLED KEYWDS 2 RECEPTOR (GPCR), MEMBRANE PROTEIN, ANTAGONIST, ENDOGENOUS LIGAND, KEYWDS 3 PSI-BIOLOGY, STRUCTURAL GENOMICS, GPCR NETWORK, LIPIDIC CUBIC PHASE KEYWDS 4 (LCP), NOVEL DISULFIDE BOND ENGINEERING, COMPOUND DESIGN, KEYWDS 5 POLYPHARMACOLOGY, LIPID RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR J.E.CHRENCIK,C.B.ROTH,M.TERAKADO,H.KURATA,R.OMI,Y.KIHARA, AUTHOR 2 D.WARSHAVIAK,S.NAKADE,G.ASMAR-ROVIRA,M.MILENI,H.MIZUNO,M.T.GRIFFITH, AUTHOR 3 C.RODGERS,G.W.HAN,J.VELASQUEZ,J.CHUN,R.C.STEVENS,M.A.HANSON,GPCR AUTHOR 4 NETWORK (GPCR) REVDAT 2 01-JUL-15 4Z36 1 JRNL REVDAT 1 03-JUN-15 4Z36 0 JRNL AUTH J.E.CHRENCIK,C.B.ROTH,M.TERAKADO,H.KURATA,R.OMI,Y.KIHARA, JRNL AUTH 2 D.WARSHAVIAK,S.NAKADE,G.ASMAR-ROVIRA,M.MILENI,H.MIZUNO, JRNL AUTH 3 M.T.GRIFFITH,C.RODGERS,G.W.HAN,J.VELASQUEZ,J.CHUN, JRNL AUTH 4 R.C.STEVENS,M.A.HANSON JRNL TITL CRYSTAL STRUCTURE OF ANTAGONIST BOUND HUMAN LYSOPHOSPHATIDIC JRNL TITL 2 ACID RECEPTOR 1. JRNL REF CELL V. 161 1633 2015 JRNL REFN ISSN 1097-4172 JRNL PMID 26091040 JRNL DOI 10.1016/J.CELL.2015.06.002 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 3 NUMBER OF REFLECTIONS : 12660 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.273 REMARK 3 R VALUE (WORKING SET) : 0.272 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 625 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.18 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.11 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2593 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2572 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2476 REMARK 3 BIN R VALUE (WORKING SET) : 0.2562 REMARK 3 BIN FREE R VALUE : 0.2793 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.51 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 117 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3014 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 3 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 95.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.89450 REMARK 3 B22 (A**2) : -7.10170 REMARK 3 B33 (A**2) : -4.79280 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.684 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 4.569 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.426 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 2.352 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.429 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.885 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.848 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3141 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4267 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1445 ; 4.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 62 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 476 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3141 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 419 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3662 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.87 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.58 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.61 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -0.3047 -18.8188 30.2925 REMARK 3 T TENSOR REMARK 3 T11: -0.1899 T22: 0.1980 REMARK 3 T33: 0.1326 T12: -0.1437 REMARK 3 T13: -0.0055 T23: 0.0353 REMARK 3 L TENSOR REMARK 3 L11: 0.7166 L22: 0.8696 REMARK 3 L33: 0.3715 L12: -0.6523 REMARK 3 L13: 0.2160 L23: -0.7267 REMARK 3 S TENSOR REMARK 3 S11: -0.0088 S12: -0.0203 S13: -0.1395 REMARK 3 S21: -0.1020 S22: 0.1233 S23: -0.0956 REMARK 3 S31: -0.0382 S32: -0.0319 S33: -0.1145 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4Z36 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000208429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-NOV-13; 30-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100; 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : APS; APS REMARK 200 BEAMLINE : 23-ID-D; 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033; 1.033 REMARK 200 MONOCHROMATOR : MIRRORS; MIRRORS REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD; MARMOSAIC REMARK 200 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12701 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 47.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.59000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE (PH 5.5), 34 - REMARK 280 38% (V/V) PEG400 AND 200 MM AMMONIUM ACETATE, LIPIDIC CUBIC REMARK 280 PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.17500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.98000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.96500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 76.98000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.17500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.96500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS HAVE INDICATED THAT THE BIOLOGICAL UNIT IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -17 REMARK 465 LYS A -16 REMARK 465 THR A -15 REMARK 465 ILE A -14 REMARK 465 ILE A -13 REMARK 465 ALA A -12 REMARK 465 LEU A -11 REMARK 465 SER A -10 REMARK 465 TYR A -9 REMARK 465 ILE A -8 REMARK 465 PHE A -7 REMARK 465 CYS A -6 REMARK 465 LEU A -5 REMARK 465 VAL A -4 REMARK 465 PHE A -3 REMARK 465 ALA A -2 REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 PRO A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ILE A 4 REMARK 465 SER A 5 REMARK 465 THR A 6 REMARK 465 SER A 7 REMARK 465 ILE A 8 REMARK 465 PRO A 9 REMARK 465 VAL A 10 REMARK 465 ILE A 11 REMARK 465 SER A 12 REMARK 465 GLN A 13 REMARK 465 PRO A 14 REMARK 465 GLN A 15 REMARK 465 PHE A 16 REMARK 465 THR A 17 REMARK 465 ALA A 18 REMARK 465 MET A 19 REMARK 465 ASN A 20 REMARK 465 GLU A 21 REMARK 465 PRO A 22 REMARK 465 GLY A 1049 REMARK 465 SER A 1050 REMARK 465 GLY A 1051 REMARK 465 GLY A 1052 REMARK 465 SER A 1053 REMARK 465 ASP A 1054 REMARK 465 SER A 1055 REMARK 465 PRO A 1056 REMARK 465 GLU A 1057 REMARK 465 ARG A 328 REMARK 465 PRO A 329 REMARK 465 LEU A 330 REMARK 465 GLU A 331 REMARK 465 VAL A 332 REMARK 465 LEU A 333 REMARK 465 PHE A 334 REMARK 465 GLN A 335 REMARK 465 GLY A 336 REMARK 465 PRO A 337 REMARK 465 HIS A 338 REMARK 465 HIS A 339 REMARK 465 HIS A 340 REMARK 465 HIS A 341 REMARK 465 HIS A 342 REMARK 465 HIS A 343 REMARK 465 HIS A 344 REMARK 465 HIS A 345 REMARK 465 HIS A 346 REMARK 465 HIS A 347 REMARK 465 ASP A 348 REMARK 465 TYR A 349 REMARK 465 LYS A 350 REMARK 465 ASP A 351 REMARK 465 ASP A 352 REMARK 465 ASP A 353 REMARK 465 ASP A 354 REMARK 465 LYS A 355 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 23 CG CD OE1 NE2 REMARK 470 ARG A 152 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1062 CG CD NE CZ NH1 NH2 REMARK 470 LEU A1106 CG CD1 CD2 REMARK 470 GLN A 286 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 24 95.78 -68.95 REMARK 500 MET A 153 -59.83 64.90 REMARK 500 ASP A 191 52.06 -143.41 REMARK 500 ASN A 194 38.69 -99.26 REMARK 500 GLN A 286 0.97 84.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 1WV A 2001 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ON3 A 2000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1WV A 2001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: GPCR-235 RELATED DB: TARGETTRACK REMARK 900 RELATED ID: 4Z34 RELATED DB: PDB REMARK 900 RELATED ID: 4Z35 RELATED DB: PDB DBREF 4Z36 A 2 232 UNP Q92633 LPAR1_HUMAN 2 232 DBREF 4Z36 A 1001 1042 UNP P0ABE7 C562_ECOLX 23 64 DBREF 4Z36 A 1056 1105 UNP P0ABE7 C562_ECOLX 78 127 DBREF 4Z36 A 248 326 UNP Q92633 LPAR1_HUMAN 249 327 SEQADV 4Z36 MET A -17 UNP Q92633 INITIATING METHIONINE SEQADV 4Z36 LYS A -16 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 THR A -15 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ILE A -14 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ILE A -13 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ALA A -12 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LEU A -11 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 SER A -10 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 TYR A -9 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ILE A -8 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PHE A -7 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 CYS A -6 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LEU A -5 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 VAL A -4 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PHE A -3 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ALA A -2 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 GLY A -1 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ALA A 0 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PRO A 1 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 CYS A 204 UNP Q92633 ASP 204 ENGINEERED MUTATION SEQADV 4Z36 TRP A 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 4Z36 GLY A 1043 UNP P0ABE7 LINKER SEQADV 4Z36 GLY A 1049 UNP P0ABE7 LINKER SEQADV 4Z36 SER A 1050 UNP P0ABE7 LINKER SEQADV 4Z36 GLY A 1051 UNP P0ABE7 LINKER SEQADV 4Z36 GLY A 1052 UNP P0ABE7 LINKER SEQADV 4Z36 SER A 1053 UNP P0ABE7 LINKER SEQADV 4Z36 ASP A 1054 UNP P0ABE7 LINKER SEQADV 4Z36 SER A 1055 UNP P0ABE7 LINKER SEQADV 4Z36 ILE A 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 4Z36 LEU A 1106 UNP P0ABE7 LINKER SEQADV 4Z36 CYS A 282 UNP Q92633 VAL 283 CONFLICT SEQADV 4Z36 GLY A 327 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ARG A 328 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PRO A 329 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LEU A 330 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 GLU A 331 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 VAL A 332 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LEU A 333 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PHE A 334 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 GLN A 335 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 GLY A 336 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 PRO A 337 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 338 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 339 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 340 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 341 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 342 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 343 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 344 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 345 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 346 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 HIS A 347 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 348 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 TYR A 349 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LYS A 350 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 351 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 352 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 353 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 ASP A 354 UNP Q92633 EXPRESSION TAG SEQADV 4Z36 LYS A 355 UNP Q92633 EXPRESSION TAG SEQRES 1 A 459 MET LYS THR ILE ILE ALA LEU SER TYR ILE PHE CYS LEU SEQRES 2 A 459 VAL PHE ALA GLY ALA PRO ALA ALA ILE SER THR SER ILE SEQRES 3 A 459 PRO VAL ILE SER GLN PRO GLN PHE THR ALA MET ASN GLU SEQRES 4 A 459 PRO GLN CYS PHE TYR ASN GLU SER ILE ALA PHE PHE TYR SEQRES 5 A 459 ASN ARG SER GLY LYS HIS LEU ALA THR GLU TRP ASN THR SEQRES 6 A 459 VAL SER LYS LEU VAL MET GLY LEU GLY ILE THR VAL CYS SEQRES 7 A 459 ILE PHE ILE MET LEU ALA ASN LEU LEU VAL MET VAL ALA SEQRES 8 A 459 ILE TYR VAL ASN ARG ARG PHE HIS PHE PRO ILE TYR TYR SEQRES 9 A 459 LEU MET ALA ASN LEU ALA ALA ALA ASP PHE PHE ALA GLY SEQRES 10 A 459 LEU ALA TYR PHE TYR LEU MET PHE ASN THR GLY PRO ASN SEQRES 11 A 459 THR ARG ARG LEU THR VAL SER THR TRP LEU LEU ARG GLN SEQRES 12 A 459 GLY LEU ILE ASP THR SER LEU THR ALA SER VAL ALA ASN SEQRES 13 A 459 LEU LEU ALA ILE ALA ILE GLU ARG HIS ILE THR VAL PHE SEQRES 14 A 459 ARG MET GLN LEU HIS THR ARG MET SER ASN ARG ARG VAL SEQRES 15 A 459 VAL VAL VAL ILE VAL VAL ILE TRP THR MET ALA ILE VAL SEQRES 16 A 459 MET GLY ALA ILE PRO SER VAL GLY TRP ASN CYS ILE CYS SEQRES 17 A 459 ASP ILE GLU ASN CYS SER ASN MET ALA PRO LEU TYR SER SEQRES 18 A 459 CYS SER TYR LEU VAL PHE TRP ALA ILE PHE ASN LEU VAL SEQRES 19 A 459 THR PHE VAL VAL MET VAL VAL LEU TYR ALA HIS ILE PHE SEQRES 20 A 459 GLY TYR VAL ALA ASP LEU GLU ASP ASN TRP GLU THR LEU SEQRES 21 A 459 ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA SEQRES 22 A 459 ALA GLN VAL LYS ASP ALA LEU THR LYS MET ARG ALA ALA SEQRES 23 A 459 ALA LEU ASP ALA GLN LYS GLY GLY SER GLY GLY SER ASP SEQRES 24 A 459 SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE ASP ILE SEQRES 25 A 459 LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU ALA ASN SEQRES 26 A 459 GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA GLU GLN SEQRES 27 A 459 LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS TYR LEU SEQRES 28 A 459 ARG ASN ARG ASP THR MET MET SER LEU LEU LYS THR VAL SEQRES 29 A 459 VAL ILE VAL LEU GLY ALA PHE ILE ILE CYS TRP THR PRO SEQRES 30 A 459 GLY LEU VAL LEU LEU LEU LEU ASP CYS CYS CYS PRO GLN SEQRES 31 A 459 CYS ASP VAL LEU ALA TYR GLU LYS PHE PHE LEU LEU LEU SEQRES 32 A 459 ALA GLU PHE ASN SER ALA MET ASN PRO ILE ILE TYR SER SEQRES 33 A 459 TYR ARG ASP LYS GLU MET SER ALA THR PHE ARG GLN ILE SEQRES 34 A 459 LEU GLY ARG PRO LEU GLU VAL LEU PHE GLN GLY PRO HIS SEQRES 35 A 459 HIS HIS HIS HIS HIS HIS HIS HIS HIS ASP TYR LYS ASP SEQRES 36 A 459 ASP ASP ASP LYS HET ON3 A2000 38 HET 1WV A2001 18 HETNAM ON3 1-(4-{[(2S,3R)-2-(2,3-DIHYDRO-1H-INDEN-2-YLOXY)-3-(3,5- HETNAM 2 ON3 DIMETHOXY-4-METHYLPHENYL)-3-HYDROXYPROPYL]OXY}PHENYL) HETNAM 3 ON3 CYCLOPROPANECARBOXYLIC ACID HETNAM 1WV (2S)-2,3-DIHYDROXYPROPYL (7Z)-TETRADEC-7-ENOATE HETSYN ON3 ONO-3080573 FORMUL 2 ON3 C31 H34 O7 FORMUL 3 1WV C17 H32 O4 FORMUL 4 HOH *3(H2 O) HELIX 1 AA1 SER A 29 SER A 37 1 9 HELIX 2 AA2 ASN A 46 ASN A 77 1 32 HELIX 3 AA3 ARG A 78 HIS A 81 5 4 HELIX 4 AA4 PHE A 82 PHE A 107 1 26 HELIX 5 AA5 ASN A 108 ARG A 114 5 7 HELIX 6 AA6 THR A 117 ARG A 152 1 36 HELIX 7 AA7 THR A 157 GLY A 179 1 23 HELIX 8 AA8 ALA A 180 VAL A 184 5 5 HELIX 9 AA9 ASP A 191 CYS A 195 5 5 HELIX 10 AB1 SER A 203 LYS A 1019 1 49 HELIX 11 AB2 ASN A 1022 GLN A 1041 1 20 HELIX 12 AB3 PHE A 1061 GLY A 1082 1 22 HELIX 13 AB4 LYS A 1083 ASN A 1099 1 17 HELIX 14 AB5 ASN A 249 CYS A 284 1 36 HELIX 15 AB6 GLU A 293 ASP A 315 1 23 HELIX 16 AB7 ASP A 315 GLY A 327 1 13 SSBOND 1 CYS A 24 CYS A 190 1555 1555 2.04 SSBOND 2 CYS A 188 CYS A 195 1555 1555 2.04 SSBOND 3 CYS A 204 CYS A 282 1555 1555 2.04 SSBOND 4 CYS A 284 CYS A 287 1555 1555 2.04 SITE 1 AC1 13 VAL A 52 THR A 109 GLN A 125 ILE A 128 SITE 2 AC1 13 ASP A 129 TRP A 210 TRP A 271 GLY A 274 SITE 3 AC1 13 LEU A 278 GLU A 293 LYS A 294 PHE A 296 SITE 4 AC1 13 LEU A 297 SITE 1 AC2 5 LEU A 51 LEU A 122 THR A 130 GLY A 179 SITE 2 AC2 5 SER A 183 CRYST1 34.350 111.930 153.960 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029112 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008934 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006495 0.00000 MASTER 369 0 2 16 0 0 6 6 0 0 0 36 END